María del Pilar de la Huerta Martínez
Director of Finance/CFO chez BIOFRONTERA AG
Profil
María del Pilar de la Huerta Martínez is currently the Director at Vaxdyn SL.
She also holds the position of Independent Non-Executive Director at 4basebio Plc since 2020.
Additionally, she is the Co-Managing Director at Biofrontera Pharma GmbH and a Member-Supervisory Board at Epidesease SL.
In her former roles, Ms. de la Huerta Martínez served as the Chief Executive Officer & Director at Noscira SA, Genetrix SL, and Araclon Biotech SL.
She was also the Chief Executive Officer & Director at Antibióticos de León SLU from 2017 to 2018.
Furthermore, she held the position of Chief Executive Officer & Director at Biotechnology Assets SA and Director-Business Development at Zeltia SA. From 2012 to 2020, she served as a Member-Supervisory Board at 2invest AG.
Ms. de la Huerta Martínez obtained her undergraduate degree from Universidad Complutense de Madrid.
Postes actifs de María del Pilar de la Huerta Martínez
Sociétés | Poste | Début |
---|---|---|
4BASEBIO PLC | Director/Board Member | 22/12/2020 |
BIOFRONTERA AG | Director of Finance/CFO | 12/09/2022 |
Epidesease SL | Director/Board Member | - |
Vaxdyn SL
Vaxdyn SL BiotechnologyHealth Technology Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain. | Director/Board Member | - |
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The private company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Chief Executive Officer | - |
Anciens postes connus de María del Pilar de la Huerta Martínez
Sociétés | Poste | Fin |
---|---|---|
2INVEST AG | Chief Executive Officer | 07/07/2017 |
Antibióticos de León SLU
Antibióticos de León SLU Pharmaceuticals: MajorHealth Technology Antibióticos de León SLU develops, manufactures, sells, and distributes active pharmaceutical ingredients for penicillin-based antibiotics. Its products include sterile antibiotics and oral semisynthesis. The company was founded in 2014 and is headquartered in Leon, Spain. | Chief Executive Officer | 25/04/2018 |
BIOTECHNOLOGY ASSETS, S.A. | Chief Executive Officer | - |
Genetrix SL
Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Chief Executive Officer | - |
░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de María del Pilar de la Huerta Martínez
Universidad Complutense de Madrid | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
2INVEST AG | Finance |
BIOFRONTERA AG | Health Technology |
BIOTECHNOLOGY ASSETS, S.A. | Health Technology |
4BASEBIO PLC | Health Technology |
Entreprise privées | 8 |
---|---|
Noscira SA
Noscira SA Miscellaneous Commercial ServicesCommercial Services Noscira SA develops and manufactures pharmaceutical products. It focuses on developing drugs for the treatment of nervous system disorders, especially the Alzheimer's disease. The company was founded in 2000 and is headquartered in Tres Cantos, Spain | Commercial Services |
Zeltia SA
Zeltia SA BiotechnologyHealth Technology Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology. It operates through the Biopharmaceuticals and Consumer Chemicals segments. The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products. The company was founded on August 3, 1939 and is headquartered in Madrid, Spain. | Health Technology |
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The private company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Commercial Services |
Araclon Biotech SL
Araclon Biotech SL Miscellaneous Commercial ServicesCommercial Services Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain. | Commercial Services |
Vaxdyn SL
Vaxdyn SL BiotechnologyHealth Technology Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain. | Health Technology |
Antibióticos de León SLU
Antibióticos de León SLU Pharmaceuticals: MajorHealth Technology Antibióticos de León SLU develops, manufactures, sells, and distributes active pharmaceutical ingredients for penicillin-based antibiotics. Its products include sterile antibiotics and oral semisynthesis. The company was founded in 2014 and is headquartered in Leon, Spain. | Health Technology |
Epidesease SL | |
Genetrix SL
Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Health Technology |